Drugs / TRO40303
last change Sep 2013 re-read 3 minutes ago

TRO40303

Small molecule

Developed for
acute myocardial infarction
Investigated by
European Commission · Hoffmann-La Roche

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01374321 Oct 2011 → Sep 2013 acute myocardial infarction Hoffmann-La Roche Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as TRO40303 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01374321 ↗
Modality Small molecule — CHEMBL4297500 ↗
Route Intravenous “injected in peripheral IV” NCT01374321 ↗